Health-related quality of life from the FALCON phase III randomised trial of fulvestrant 500 mg versus anastrozole for hormone receptor-positive advanced breast cancer.

John F R Robertson,Kwok-Leung Cheung,Shinzaburo Noguchi,Zhimin Shao,Arnold Degboe,Jasmine Lichfield, Jackie Thirlwell,Mehdi Fazal,Matthew J Ellis

European Journal of Cancer（2018）

引用 14|浏览29

暂无评分

摘要

•A post-hoc analysis of health-related quality of life in the phase III FALCON study.•HRQoL assessed during treatment and post discontinuation with FACT-B questionnaire.•HRQoL was maintained and comparable with fulvestrant versus anastrozole.

查看译文

关键词

Anastrozole,FALCON,Fulvestrant,Health-related quality of life,Locally advanced or metastatic breast cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要